EDESA BIOTECH, INC. Income Taxes Paid
EDESA BIOTECH, INC. (EDSA) reported Income Taxes Paid of $800 for the 6-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2019-05-08
- EDESA BIOTECH, INC. income taxes paid, net for the quarter ending 2019-03-31 was $800.00.
- EDESA BIOTECH, INC. income taxes paid, net for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- EDESA BIOTECH, INC. income taxes paid, net for the quarter ending 2018-09-30 was $0.00.
- EDESA BIOTECH, INC. income taxes paid, net for the quarter ending 2018-06-30 was $0.00.
- EDESA BIOTECH, INC. income taxes paid, net for fiscal 2018 was $800.00, a 0.00% change from fiscal 2017.
- EDESA BIOTECH, INC. income taxes paid, net for fiscal 2017 was $800.00, a 88.89% decline from fiscal 2016.
- EDESA BIOTECH, INC. income taxes paid, net for fiscal 2016 was $7.20K, a 80.43% decline from fiscal 2015.
- EDESA BIOTECH, INC. income taxes paid, net for fiscal 2015 was $36.80K, a 21.85% increase from fiscal 2014.
| Period end | Income Taxes Paid, Net 1 month | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | $800.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $800.00 10-Q · filed 2019-05-08 | $800.00 derived: sum of 3 quarters · filed 2019-05-08 | $800.00 derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-05 | $0.00 derived: sum of 2 quarters · filed 2019-02-05 | $0.00 derived: sum of 3 quarters · filed 2019-02-05 | $0.00 derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $0.00 derived: sum of 2 quarters · filed 2018-11-30 | $0.00 derived: sum of 3 quarters · filed 2019-05-08 | $800.00 10-K · filed 2018-11-30 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | $0.00 derived: sum of 2 quarters · filed 2019-05-08 | $800.00 10-Q · filed 2018-08-08 | $800.00 derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $800.00 10-Q · filed 2019-05-08 | $800.00 derived: sum of 3 quarters · filed 2019-05-08 | $800.00 derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $800.00 10-Q · filed 2019-02-05 | $800.00 derived: sum of 2 quarters · filed 2019-02-05 | $800.00 derived: sum of 3 quarters · filed 2019-02-05 | $800.00 derived: sum of 4 quarters · filed 2019-02-05 | |
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $0.00 derived: sum of 2 quarters · filed 2018-11-30 | $0.00 derived: sum of 3 quarters · filed 2018-11-30 | $800.00 10-K · filed 2018-11-30 | |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | $0.00 derived: sum of 2 quarters · filed 2018-08-08 | $800.00 10-Q · filed 2018-08-08 | $800.00 derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | $800.00 10-Q · filed 2018-05-07 | $800.00 derived: sum of 3 quarters · filed 2018-05-07 | $800.00 derived: sum of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | $800.00 10-Q · filed 2018-02-07 | $800.00 derived: sum of 2 quarters · filed 2018-02-07 | $800.00 derived: sum of 3 quarters · filed 2018-02-07 | $800.00 derived: sum of 4 quarters · filed 2018-02-07 | |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $0.00 derived: sum of 2 quarters · filed 2017-12-01 | $0.00 derived: sum of 3 quarters · filed 2017-12-01 | $7.20K 10-K · filed 2017-12-01 | |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $0.00 derived: sum of 2 quarters · filed 2017-08-09 | $7.20K 10-Q · filed 2017-08-09 | $16.20K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09 | $7.20K 10-Q · filed 2017-05-09 | $16.20K derived: sum of 3 quarters · filed 2017-12-01 | $25.20K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-12-31 | $7.20K 10-Q · filed 2017-02-06 | $16.20K derived: sum of 2 quarters · filed 2017-12-01 | $25.20K derived: sum of 3 quarters · filed 2017-12-01 | $34.20K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-09-30 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $18.00K derived: sum of 2 quarters · filed 2017-12-01 | $27.00K derived: sum of 3 quarters · filed 2017-12-01 | $36.80K 10-K · filed 2017-12-01 | |
| 2015-06-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $18.00K derived: sum of 2 quarters · filed 2016-08-09 | $27.80K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09 | $18.80K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $9.80K 10-Q · filed 2016-02-08 | ||||
| 2014-09-30 | $800.00 10-K · filed 2016-12-14 | ||||
| 2014-08-31 | $30.20K 10-K · filed 2016-12-14 | ||||
| 2014-06-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | $20.40K derived: sum of 2 quarters · filed 2015-08-10 | $21.20K 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $11.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11 | $12.20K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $800.00 10-Q · filed 2015-02-09 | ||||
| 2013-08-31 | $800.00 10-K · filed 2015-12-14 | ||||
| 2012-08-31 | $800.00 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |